| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-05 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-05 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-05 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.29 |
0.0001 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0001 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.29 |
0.0002 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |